Abstracts
Submit Abstract (Overseas)
- HOME
- Abstracts
- Submit Abstract (Overseas)
The LMCE 2016 Organizing Committee cordially invites you to submit abstracts for oral and poster presentations. All congress abstracts must be submitted online via the "Online Submission System.“ Submitted abstracts will be reviewed by the Scientific Program Committee. The presentation type may possibly be changed following review by the Scientific Committee.
Abstract submission does not constitute registration for the congress and presenters are required to register for the conference separately. Please read the guidelines carefully before submitting your abstract.
Abstract submission does not constitute registration for the congress and presenters are required to register for the conference separately. Please read the guidelines carefully before submitting your abstract.
Important Dates
- -Deadline for abstract submission: July 29, 2016
- -Notification of abstract acceptance: August 19, 2016
Abstract Submission Topics
| No. | Topic | Sub Topic |
|---|---|---|
| 1 | Clinical Chemistry | Arterial blood gas analysis and electrolytes |
| Congenital metabolic disorders | ||
| Endocrine function tests | ||
| Intermediate metabolites and inorganic ions | ||
| Kidney function and urinalysis | ||
| Liver/biliary function test | ||
| Method evaluation/reference interval | ||
| Proteins | ||
| Sampling, storage, and physiological variations | ||
| Therapeutic drug monitoring and toxicology | ||
| Tumor markers | ||
| Others | ||
| 2 | Clinical Microbiology | Acid-fast bacilli |
| Antimicrobials and sensitivity test | ||
| Automated microbial identification/instrument | ||
| Bacteria | ||
| Fungus | ||
| Infection control | ||
| Mycoplasma and rickettsia | ||
| Virus | ||
| Others | ||
| 3 | Diagnostic Genetics | Cancer genetics |
| Hereditary disorders | ||
| Infectious diseases | ||
| Others | ||
| 4 | Diagnostic Hematology | Automated analyzers |
| Coagulation and hemostasis | ||
| Platelet disorders | ||
| RBC disorders | ||
| WBC disorders-benign | ||
| WBC disorders-malignant | ||
| Others | ||
| 5 | Diagnostic Immunology | Allergic diseases |
| Cancer immunology | ||
| HLA and transplantation | ||
| Inflammatory mediators | ||
| Serological test for HBV infection | ||
| Serological test for other infectious diseases | ||
| Serological test for syphilis | ||
| Others | ||
| 6 | Transfusion Medicine | Blood components |
| Blood typing | ||
| Hematopoietic stem cell | ||
| RBC antigen/antibody | ||
| Therapeutic apheresis/cell therapy | ||
| Transfusion reaction | ||
| Transfusion therapy | ||
| Others | ||
| 7 | General Laboratory Medicine | Laboratory informatics |
| Point-of-care test | ||
| Others |
Steps for Abstract Submission
-
Step 1Click the Abstract Submission button
-
Step 2Sign up or Log in
-
Step 3Fill out Participant Info and Click “Add”
-
Step 4Complete Abstract Submission and Author Info
Section -
Step 5Save and Review until August 4, 2016
- *The abstract submission site works best using a PC with Internet Explorer. The site is not designed for use with tablet browsers, iPads, or Android Devices.
- *국내 참가자 분은 반드시 국내 전용으로 초록 접수를 하시기 바랍니다. 국내 초록 접수 바로가기
Abstract Submission Guidelines
- *All abstracts must be submitted online prior to June 30, 2016. For instructions regarding online submission, please click the button.
- *Abstracts must be written in clear English and limited to 400 words.
- -An abstract consists of a title, author name ‘s and affiliation, the text of the submission and keywords
- -Title: Capitalize the first letter of each word
- -The abstract body text should be structured chronologically into four sections: Background, Methods, Results, Conclusions
- -No tables or images are allowed
- -Keywords: No more than 6 keywords which the first word begins with a capital letter
- *No additional proofreading or corrections will be allowed after the submission deadline. It is the responsibility of the authors to ensure that their text does not contain typos or grammatical errors.
- *Authors have the option of choosing their presentation type (oral presentation, poster presentation or poster exhibition). However, the scientific program committee will make the final decision after review.
- *Acknowledgment of your submission will be sent to the e-mail address provided by the corresponding author. If you do not receive this e-mail confirmation, it means we have not received your abstract. If you are sure you have submitted it, check to make sure you sent it to the correct e-mail address.
- *The e-mail you provided us will be used to notify you of the acceptance and to send you updated information.
If you have any inquiries, please contact the congress Secretariat at seoul@lmce2016.org. - *The content must not have been published previously in a copyrighted, peer reviewed journal (such as Clinical Chemistry) by any one or more of the submitting authors.
Notification of Acceptance
- *All submitted abstracts will be reviewed by the Scientific Program Committee according to reviewing procedures.
- *Notification of acceptance will be sent by e-mail to corresponding, presenting and abstract submitting authors by August 19, 2016.
- *The presenting author should reply to the acceptance notification for confirmation of attendance.
Abstract Withdrawal
- *If the presenting author of an accepted abstract does not register by September 29, 2016, the abstract will be automatically withdrawn from the final program.
- *If you have to withdraw an abstract, please notify the secretariat (seoul@lmce2016.org) in writing as soon as possible.
- Supported by
